Abstract The American Society for Reproductive Medicine estimates that fewer than a
quarter of infertile couples have sufficient access to infertility care. Insurers in the United …

In the past decade, genetic testing for cardiac disease has become part of routine clinical
care. A genetic diagnosis provides the possibility to clarify risk for relatives. For family …

BACKGROUND The genetic composition of embryos generated by in vitro fertilization (IVF)
can be examined with preimplantation genetic testing (PGT). Until recently, PGT was limited …

Through preimplantation genetic diagnosis, genetic diseases can be detected during the
early stages of embryogenesis, but effective treatments for many of these disorders are …

The United States has the most expensive health care system in the world, spending more
than $4 trillion annually on health care. 1 Despite this exorbitant price tag and a complex …

Background While anti-Müllerian hormone (AMH) predicts quantitative IVF outcomes such
as oocyte yield, it is not certain whether AMH predicts markers of oocyte quality such as …

Objective To assess the impact of statutory federal and state exceptions to the state law
mandating insurance coverage for the diagnosis and treatment of infertility. Design …

Objective To describe characteristics, trends, and outcomes of international gestational
surrogacy cycles in the United States (US). Design Retrospective cohort study. Setting All …

In recent years, there has been rapid increase in the availability of elective sex selection via
genetic testing of preimplantation embryos created through in vitro fertilization. We explore …

Purpose Investigate patient preferences in embryo selection for transfer regarding quality
versus sex in IVF/ICSI cycles with PGT-A and assess associated clinical implications …